Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

LTRNLTRN
Showing 8 of 22 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in LANTERN PHARMA INC

GEODE CAPITAL MANAGEMENT, LLC holds 102,819 shares of LTRN (LANTERN PHARMA INC), worth $428,852 as of 2026-Q2. The position was decreased (-7.9% shares).

Current Value

$428,852

Current Shares

102,819

Total Value Change

+$107,894

Total Shares Change

+15,384

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
102,819
-7.9%
$428,8520.0%$4.17
0
2026-Q1
Increased
111,646
+15.4%
$152,9840.0%$2.71
18
2025-Q4
Increased
96,742
+5.1%
$293,1910.0%$3.06
17
2025-Q3
Increased
92,081
+0.2%
$400,6470.0%$4.54
16
2025-Q2
Increased
91,891
+1.5%
$290,4380.0%$3.19
16
2025-Q1
Increased
90,504
+4.1%
$320,4700.0%$3.55
17
2024-Q4
Decreased
86,973
-0.5%
$277,5210.0%$3.27
0
2024-Q3
Increased
87,435
+1.3%
$320,9580.0%$3.78
16

Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used